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Abstract Protein misfolding has been proposed to be a
common pathogenic mechanism in many inborn errors of
metabolism including cystathionine β-synthase (CBS) defi-
ciency. In this work, we describe the structural properties of
nine CBS mutants that represent a common molecular
pathology in the CBS gene. Using thermolysin in two
proteolytic techniques, we examined conformation of these
mutants directly in crude cell extracts after expression in E.
coli. Proteolysis with thermolysin under native conditions
appeared to be a useful technique even for very unstable
mutant proteins, whereas pulse proteolysis in a urea gradient
had limited values for the study of the majority of CBS
mutants due to their instability. Mutants in the active core
had either slightly increased unfolding (p.A114V, p.E302K
and p.G307S) or extensive unfolding with decreased stability
(p.H65R, p.T191M, p.I278T and p.R369C). The extent of
the unfolding inversely correlated with the previously
determined degree of tetrameric assembly and with the
catalytic activity. In contrast, mutants bearing aminoacid
substitutions in the C-terminal regulatory domain (p.R439Q
and p.D444N) had increased global stability with decreased
flexibility. This study shows that proteolytic techniques can
reveal conformational abnormalities even for CBS mutants
that have activity and/or a degree of assembly similar to the
wild-type enzyme. We present here a methodological
strategy that may be used in cell lysates to evaluate
properties of proteins that tend to misfold and aggregate
and that may be important for conformational studies of
disease-causing mutations in the field of inborn errors of
metabolism.
Introduction
Protein misfolding plays a role in the pathogenesis of many
diseases, including inborn errors of metabolism, such as
phenylketonuria due to phenylalanine hydroxylase defi-
ciency, lysosomal storage disorders and various acyl-CoA
deficiencies (Muntau and Gersting 2010). Aberrant folding
of mutant proteins may be repaired by treatment of patients
with chaperones, and the possible rescue of the mutants
represents an interesting option for successful therapy of
conformational disorders (Leandro and Gomes 2008). The
efficacy and specificity of the search for novel compounds
with chaperone activity may be significantly increased if
detailed knowledge of the structural mechanisms underly-
ing the misfolding of the mutants is available. This has
been demonstrated by the implementation of a novel
therapy for phenylketonuria using sapropterin (Muntau et
al. 2002), which possibly acts a pharmacological chaperone
(Erlandsen et al. 2004; Pey et al. 2004; Perez et al. 2005).
Homocystinuria due to cystathionine beta-synthase
(CBS) deficiency is a common enzymopathy that affects
Communicated by: Niels Gregersen
Competing interests: None declared.
Electronic supplementary material The online version of this article
(doi:10.1007/s10545-011-9407-4) contains supplementary material,
which is available to authorized users.
A. Hnízda: K. Raková: V. Kožich (*)
Institute of Inherited Metabolic Disorders,
First Faculty of Medicine, Charles University in Prague
and General University Hospital in Prague,
Ke Karlovu 2,
128 08, Prague 2, Czech Republic
e-mail: viktor.kozich@LF1.cuni.cz
V. Jurga
Department of Biochemistry and Microbiology,
Institute of Chemical Technology in Prague,
Technická 5,
166 28, Prague 6, Czech Republic
J Inherit Metab Dis (2012) 35:469–477
DOI 10.1007/s10545-011-9407-4the metabolism of sulfur amino acids and manifests
clinically as a multisystemic disease (Mudd et al. 2001;
Skovby et al. 2010). It has been proposed that many
missense mutations in the CBS gene disrupt correct protein
folding. This notion was supported by several lines of
evidence, including the abnormal migration of mutant
proteins in native electrophoresis (Janosik et al. 2001b;
Kozich et al. 2010), the decreased solubility of mutants in
SDS (Kozich et al. 2010) and the increased rate of
proteasome-dependent proteolysis (Singh and Kruger
2009). The misfolding of CBS mutants was also inferred
from the rescue of mutant enzymes by chemical chaperones
(Singh et al. 2007; Majtan et al. 2010; Kopecka et al. 2011),
CBS ligands (Kopecka et al. 2011), proteasome inhibitors
(Singh et al. 2010), or by expression under temperature
permissive to folding (Kozich et al. 2010). Taken together,
all these experiments strongly indicate that misfolding plays
an important role in CBS deficiency; however, the
conformational changes underlying the abnormal folding
have not been studied in detail.
Biophysical techniques used for conformational studies
require relatively large amounts of purified proteins.
However, only a few CBS mutants have been successfully
produced as recombinant proteins in E. coli, purified to
homogeneity in sufficient yields and structurally character-
ized, including the C-terminal mutants p.I435T, p.S466L
(Janosik et al. 2001a) and p.D444N (Evande et al. 2002;
Sen et al. 2005) and a double-linked mutant p.P78R/K102N
(Sen and Banerjee 2007). Six additional CBS mutants (p.
P49L, p.P78R, p.A114V, p.R125Q, p.E176K, p.P422L)
were successfully purified in the presence of chemical
chaperones in the culture media (Majtan et al. 2010).
Because chaperones facilitate correct folding, it is not
surprising that the chaperoned mutants did not exhibit gross
structural abnormalities. It should be also noted that during
the purification procedure, an unknown portion of mis-
folded and aggregated proteins may be lost and, conse-
quently, the structural information about this fraction may
not be obtained from studying purified proteins.
To study mutants that are not amenable to purification,
proteolytic techniques in crude cell extracts may be used. It
has been demonstrated that protein folding may be studied
quantitatively by employing thermolysin, even in crude cell
extracts (Chang and Park 2009; Kim et al. 2009). The
methodology comprises two techniques: proteolysis under
native conditions and pulse proteolysis in a urea gradient.
The rate of proteolysis under native conditions reveals the
extent of unfolding in the conformational ensemble of
studied proteins because proteases can only cleave flexible
regions and partially or globally unfolded structures (Young
et al. 2007). Pulse proteolysis is a technique that uses
thermolysin to monitore urea-induced unfolding. After a
short proteolytic pulse, the fraction of folded proteins
remains uncleaved and the unfolded species are digested.
Using this premise, the cm value, a measure of protein
thermodynamic stability in the urea gradient, may be
determined (Park and Marqusee 2005).
In the present work, we applied these recently developed
techniques, whose feasibility for the conformational study
of CBS was shown using purified wild-type proteins
(Prudova et al. 2006; Hnizda et al. 2010), to study CBS
mutants expressed in E. coli.F o rt h e s ea n a l y s e s ,w e
selected the three most prevalent mutants and six additional
mutants at different locations within the CBS molecule, and
we examined if the conformation of the CBS mutant differs
from the wild-type enzyme.
Results
Selection of CBS mutants The mutations selected for this
study are located in different domains of the CBS molecule
(Meier et al. 2003; Yamanishi et al. 2006; Hnizda et al.
2010) (see Table 1). Advanced molecular modelling of the
impact of mutations on enzyme structure could not be
performed with sufficient reliability because the 3-D
structure of human full-length wild-type CBS has not been
experimentally solved at atomic resolution. As reported
previously, these mutants vary in the degree of correct
assembly and subsequent tetramer formation as well as in
the levels of their catalytic activity (Kozich et al. 2010).
Determination of proteolytic kinetics under native
conditions We optimized the previously described proce-
dure (Chang and Park 2009) and final experimental
conditions designed to evaluate the proteolytic cleavage of
wild-type CBS in crude extracts over a time course of 20
min (for details, see Methods). The analysis of proteolytic
cleavage using SDS-PAGE (Fig. 1) and native electropho-
resis (Fig. S1 available in Supplementary_Info.pdf) did not
reveal the presence of any partially cleaved fragments or
unfolded intermediates, respectively. Therefore, the
assumption for a model to describe protein unfolding
and consequent proteolysis of CBS by thermolysin in
which there is an equilibrium between folded tetramers
and unfolded monomers (Park and Marqusee 2004a)w a s
satisfied. Because the opening of the folded structure is
necessary for sufficient proteolysis (Park and Marqusee
2004b; Chang and Park 2009), the determination of
proteolytic kinetics provides data on the extent of the
unfolding of the conformational ensemble.
The quantitative analysis of proteolysis under native
conditions revealed that the CBS protein in crude cell
extract comprises two different fractions. The major
fraction of wild type CBS (≈80%) was cleaved via the
first-order kinetics while the minor portion (≈20%)
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The data from the proteolytic kinetics of wild-type CBS
were consistent with Eq. 1 (see Methods; r
2=0.9066; see
Fig. S2A available in Supplementary_Info.pdf) and they
show that the proteolysis with thermolysin under native
conditions provides two parameters about the CBS pro-
teins: the proteolytic rate of the major fraction and the
relative abundance of the fraction that resists proteolysis
during experiments.
Analysis of CBS mutants by native proteolysis The kinetics
of proteolysis under native conditions was successfully
determined for all mutants. We show here that this method
is robust and that it can be used for the analysis of even
extremely unstable proteins.
All mutant proteins possessing an aminoacid substitution
in the active core were cleaved too rapidly using the same
default conditions for the capture of their proteolytic
courses (Fig. 1). Therefore, the unstable mutants were
exposed to lower and varying concentrations of thermoly-
sin, which enabled the observation of the proteolytic time
course and subsequent determination of its kinetics
(Fig. S3, available in Supporting_Info.pdf). Because the
dependence of the kinetic constant kobs on the thermolysin
concentration appeared to be linear (as shown for wild-type
CBS in Fig. S2B, available in Supplementary_Info.pdf), the
proteolytic susceptibility of CBS mutants was assessed by
comparing the kp values expressed in M
−1 min
−1; that is,
kobs divided by the molar concentration of thermolysin in
the proteolytic reaction (Park and Marqusee 2004b).
A significant increase in the proteolytic rates was
observed for all mutants located in the active core, Fig. 1
illustrates the proteolysis of the mutants under the same
conditions, and Table 2 provides the quantitative compar-
isons of the kinetic constant kp for the analyzed proteins.
Unfortunately, faster cleavage of the active core mutant p.
I278T could not be reliably quantified due to poor
reproducibility of the proteolytic cleavage of this mutant
Fig. 1 Proteolytic kinetics under native conditions for wild-type and
mutant CBS proteins. Cell lysates (1 mg/ml protein) were cleaved by
thermolysin (0.2 mg/ml). The amount of uncleaved protein was
determined by Western blot followed by immunodetection with CBS
antibody. Time points are depicted in minutes
Table 1 List of CBS mutants analyzed in this study.
Protein Location of the
mutated residue
The number of tetramers
(% of wild-type)
Relative enzyme activity
(% of wild-type activity)
Reference for the
location of the mutation
p.H65R heme-binding pocket 23.1 3.9 (Meier et al. 2003)
p.A114V dimer interface of the
active core
73.7 76.9 (Meier et al. 2003)
p.T191M solvent-exposed at the
periphery of the active core
1.7 0.3 (Kozich et al. 2010)
p.I278T buried in the active core 1.0 0.3 (Meier et al. 2003)
p.E302K regulatory interface 90.7 95.4 (Meier et al. 2003; Hnizda et al. 2010)
p.G307S catalytic site 111.7 0.2 (Meier et al. 2003)
p.R369C regulatory interface 7.8 1.8 (Yamanishi et al. 2006)
p.R439Q regulatory domain 117.6 117.2 (Kozich et al. 2010)
p.D444N regulatory domain -
AdoMet binding site
120.2 163.8 (Hnizda et al. 2010; Kozich et al. 2010)
Relative enzyme activities and the number of tetramers are expressed as a mean value from data published elsewhere (Kozich et al. 2010).
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value of kp was observed for mutations located in the
regulatory domain, suggesting a rigidification of their
conformation.
In the next step, we compared the B values, which give
the relative abundance of proteolytically resistant fractions
of CBS proteins revealed from the determination of
proteolytic kinetics. It should be noted that cleavage with
lower concentrations of thermolysin might lead to an
overestimation of the uncleaved protein fraction, as shown
for wild-type CBS in Fig. S2C (available in the Supple-
mentary_Info.pdf). However, an increased B value was not
observed for any of the mutants analyzed in this study
(Table 2). In contrast to wild-type CBS, several mutants
(p.H65R, p.I278T, p.E302K and p.G307S) exhibited a
decreased B value an increased kp. These results indicate
that the conformer distribution in the structural ensemble of
these mutants may possibly be shifted towards the unfolded
intermediates.
In summary, proteolysis under native conditions revealed
that all mutants had a different degree of structural
flexibility. Mutations in the active core had an increased
extent of protein unfolding, whereas mutations in the
regulatory domain tended to form more rigid protein
structures.
Pulse proteolysis A previously developed procedure for
pulse proteolysis of purified CBS (Hnizda et al. 2010) was
successfully adopted for crude cell extracts and the data for
wild-type CBS followed the two-state unfolding model
(r
2=0.9562; Fig. S2D available in Supplementary_Info.
pdf). Pulse proteolysis therefore describes an equilibrium
between folded tetramers and unfolded monomers in a
urea gradient; the validity of this model is further
supported by a previous study (Kery et al. 1998) reporting
that higher concentrations of urea lead to the dissociation
of CBS tetramers.
Because a proportion of folded wild-type CBS was
cleaved during the proteolytic pulse even in the absence of
urea (see proteolysis under native conditions), a possible
systematic error in the determination of cm was assessed
according to a previously described procedure (Park and
Marqusee 2005, 2006). The kinetic constant for proteolysis
in 2.5 M urea was determined to be 0.13±0.01 min
−1 (see
Fig. S4, available in Supplementary_Info.pdf), indicating
negligible cleavage of folded protein during the proteolytic
pulse at the beginning of the transition zone and,
consequently, the absence of a systematic error (Park and
Marqusee 2006).
It should also be noted that the cm calculated from the
pulse proteolysis of multimeric protein does not simply
represent global protein stability (ΔGunf°) and that the
structural stability of the protein is dependent on its
concentration (Park and Marqusee 2004a). However, the
amount of CBS mutants in cell extracts was similar to or
slightly less than the wild-type protein (Fig. S5, available in
Supplementary_Info.pdf). A significant decrease in protein
level to ~20% of wild-type enzyme was observed only for
p.I278T. Although the decreased amount of p.I278T might
lead to an underestimation of its stability, the experiments
with a decreased amount of wild-type CBS (described in
Materials and methods) did not reveal any changes in the
apparent cm values. It was also proposed that, in spite of
some limitations, cm values are still valuable for comparing
protein stability under the same conditions (Schlebach et al.
2010). Consequently, we employed pulse proteolysis in a
urea gradient for conformational studies of CBS mutants in
crude cell extracts.
Analysis of CBS mutants using pulse proteolysis in a urea
gradient Pulse proteolysis in a urea gradient was used for
six mutant proteins, whereas three mutants (p.H65R, p.
E302K and p.G307S) were cleaved rapidly during the
proteolytic pulse in the absence of urea, and less than 10%
of the CBS protein remained uncleaved. It has been shown
that pulse proteolysis in a urea gradient cannot be used for
rapidly cleaved proteins (Chang and Park 2009).
Analysis of the mutantions in the regulatory-domain
revealed higher cm values as a measure of increased protein
Table 2 Proteolytic kinetics of the CBS mutants under native
conditions and pulse proteolysis in a urea gradient
Proteolysis under native conditions Pulse proteolysis
Protein kp (10
6.M
−1.min
−1) B (%) Cm [M]
Wild-type 0.30±0.04 24.4±1.7 3.05±0.03
p.H65R 38.4±5.1 8.2±2.1 N.D
p.A114V 2.2±0.4 24.1±2.5 2.84±0.04*
p.T191M 44.3±8.8 22.9±3.0 2.4**
p.I278T <2, 64.5>*** 19.5±1.2 2.42±0.01
p.E302K 5.0±0.6 0±3.3 N.D
p.G307S 4.6±0.4 0±0.1 N.D
p.R369C 24.0±3.5 23.4±1.9 2.59±0.09
p.R439Q 0.02±0.01 25.7±9.6 3.49±0.04
p.D444N 0.03±0.01 28.4±6.2 3.32±0.04
kp, B and cm values were determined by nonlinear data fitting from
four different measurements. Representative gels with corresponding
plots are shown in the Supplementary materials.
*The determination of cm for p.A114V neglected the cleavage of
partially folded forms.
**Values were determined by visual inspection because these data
could not be evaluated by nonlinear data fitting.
***kp could not be exactly determined due to low reproducibility at
lower concentrations of thermolysin.
N.D. not determined due to the rapid proteolysis in the absence of
urea.
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mentary_Info.pdf). However, we experienced several diffi-
culties during the evaluation of mutants with an increased
rate of proteolysis observed under native conditions
(p.A114V, p.T191M, p.I278T and p.R369C). In the case
of the slightly unfolded mutant p.A114V, we observed a
significant proteolytic susceptibility at the beginning of the
apparent transition zone (Fig. S4 in Supplemetary_Info.
pdf), and the requirement for the kinetic constant to be less
than 0.2 min
−1 for an accurate determination of cm was
therefore not satisfied. Despite this, pulse proteolysis can
yield at least partial knowledge about the urea-induced
transition between the partially and globally unfolded
fractions. An analysis accounting for a systematic error
(see Fig. S7, available in Supplementary_Info.pdf) showed
that the correct value of cm could in fact be lower that the
apparent value. Taken together, both the corrected and
uncorrected value of cm indicated that the protein stability
of the mutant p.A114V was at least slightly decreased
compared to wild-type CBS.
Another type of obstacle arose during the pulse
proteolysis of severely unfolded proteins, p.T191M, p.
I278T and p.R369C. The amount of CBS mutants in cell
lysates decreased after the overnight incubation even in the
absence of urea in the uncleaved control samples, perhaps
due to the formation of precipitates that did not enter into
the electrophoretic gel (a representative gel together with a
quantitative comparison of the amount of soluble CBS
antigen before and after overnight incubation is shown in
Fig. S8, available in Supplementary_Info.pdf).Therefore,
pulse proteolysis could only be assessed for the soluble
fraction of these mutants. Interestingly, the proteins were
not significantly cleaved at the beginning of their apparent
transition zone, indicating the reliable determination of
these values (Fig. S4 in Supplementary_Info.pdf). The
analyses showed a significant decrease in the stability of
these mutant proteins, which is consistent with the higher
extent of unfolding revealed by native proteolysis. However,
these results should be interpreted with great care because we
analyzed only the limited fraction of the conformational
ensemble that did not precipitate.
It should be noted here that the reported difficulties in
pulse proteolysis are most likely caused by the instability of
the mutants. Various modifications of experimental proce-
dures, such as a lower amount of thermolysin in the assay
or a shorter equilibration time of cell lysates in urea, did not
improve the outcome of the experiments (data not shown).
This suggests that pulse proteolysis in a urea gradient for
the conformational analysis of highly unstable mutant
proteins may be of limited value. In spite of these
limitations, pulse proteolysis showed that the different
extent of the unfolding of CBS mutants is associated with
corresponding changes in protein stability: unfolded mutant
proteins had lower stability, whereas rigidified mutants
were more stable than wild-type CBS.
Correlation of protein unfolding with the degree of tetramer
assembly and with enzyme activity of CBS mutants The
data from proteolysis under native conditions were corre-
lated with the number of correctly assembled tetramers and
their catalytic activity, which was reported in a previous
study (Kozich et al. 2010). The relative positions of the
mutations are similar in both plots, with the exception of
the catalytic site mutant p.G307S (compare Fig. 2a and b).
The plots show that hypoactive and incorrectly assembled
mutants had a higher extent of protein unfolding, whereas
hyperactive and properly assembled mutants were more
rigidified that wild-type CBS. This analysis indicates a
trend between the proteolytic resistance, kp, and the number
of tetramers (R
2=0.6646; p=0.0074) and enzyme activity
(R
2=0.7566; p=0.0015) (Fig. 2). These data may imply that
an optimal degree of conformational flexibility is a
Fig. 2 Conformational properties of CBS mutants: proteolytic data
correlated with enzyme activity and with the degree of tetrametric
assembly. The dependence of the proteolytic kinetics with thermolysin
under native conditions (ln (kp)) on the enzyme activity of the CBS
mutants (A) and on the number of assembled tetramers (B) – the
correlation analysis indicates a possible trend between the proteolytic
resistance and the number of tetramers (R
2=0.6646; p=0.0074) and
enzyme activity (R
2=0.7566; p=0.0015). All values for the mutants
are normalized to the number of tetramers or activity of the wild-type
as appropriate
J Inherit Metab Dis (2012) 35:469–477 473necessary condition for correct tetrameric assembly which
further determines the catalytic efficiency of CBS mutants.
Discussion
In this study, we describe conformational properties of nine
disease-causing CBS mutants that previously resisted
purification and further characterization. By using proteol-
ysis of mutants in crude cell extracts under native
conditions and pulse proteolysis in a urea gradient, we
demonstrated that the conformational properties of all
analyzed mutants differ from the wild-type protein. Based
on these data, we propose a possible molecular mechanism
for the misfolding and misassembly of CBS mutants. Using
a modified mathematical model for the folded tetramers-
unfolded monomers equilibrium (Park and Marqusee
2004a), mutants may be divided into three major groups:
i) Severely misassembled mutants with low residual activity
and extensive unfolding (p.H65R, p.T191M, p.I278Tand
p.R369C). These mutants predominantly form aggregates
that are likely composed of weakly interacting subunits
with unfolded regions of high sensitivity to proteolytic
cleavage.
ii) Correctly assembled mutants that are only slightly
unfolded (catalytically active p.A114V and p.E302K
and the inactive p.G307S located in the active site).
These proteins are characterized by increased unfolding
through kinetically and/or thermodynamically more
favourable formation of unfolded intermediates.
iii) Correctly assembled hyperactive mutants that are
more stable and more tightly folded (p.R439Q and
p.D444N) due to a decreased formation of unfolded
species.
Altered conformational properties of CBS mutants may
affect protein turnover in vivo The higher proteolytic
susceptibility of the majority of CBS mutants in this study
indicates their inclination to unfolding. This observation is
consistent with previous work by Singh and Kruger
demonstrating that the most common mutant, p.I278T,
exhibited accelerated ubiquitin-dependent proteolysis in S.
cerevisiae and that turnover of the mutated protein could
have been altered by a manipulation of the levels of heat
shock proteins (Singh and Kruger 2009). Furthermore,
several mutants were rescued by treatment with the
proteasome inhibitor bortezomib in yeast or by MG132 in
patient-derived fibroblasts (Singh et al. 2010), indicating
that more rapid degradation plays an important role in the
pathophysiology of CBS deficiency.
All these data are consistent with a hypothesis that the
unfolded intermediates of CBS mutants may be rapidly
degraded by proteasome-dependent proteolysis. Increased
protein unfolding was reported for oligomeric enzymes that
are deficient in other inherited metabolic diseases such as
S-adenosylhomocysteine hydrolase (Beluzic et al. 2006),
medium chain acyl-CoA dehydrogenase (Maier et al. 2009)
and electron transfer flavoprotein (Schiff et al. 2006).
Furthermore, the relationship between increased proteolytic
susceptibility in vitro and accelerated proteasome-dependent
turnover in vivo was also demonstrated for misfolded mutants
of alanine:glyoxylate aminotransferase (Coulter-Mackie and
Lian 2006, 2008) and phenylalanine hydroxylase (Waters et
al. 1999; Gersting et al. 2008).
Conversely, mutations in the regulatory domain of CBS
led to an increase in proteolytic stability. This indicates that
the conformation of these mutants is less flexible than of
the wild-type protein. It remains to be addressed how the
increased conformational rigidity and hyperactivity of the
C-terminal mutants could result in their pathogenicity in
vivo. In previous studies, the representative C-terminal
mutants, p.I435T, p.D444N and p.S466L, had higher
activity than the wild-type enzyme together and a lower
affinity towards an allosteric activator of CBS, S-adenosyl-
methionine (AdoMet), and they failed to change conforma-
tion upon AdoMet binding (Janosik et al. 2001a; Evande et
al. 2002; Sen et al. 2005). Based on these observations, it
was proposed that the altered response to AdoMet may play
a role in the pathogenicity of these C-terminal mutations
(Yamanishi et al. 2006; Kozich et al. 2010). Interestingly,
other work showed that the expression of the C-terminal
mutant p.S466L in a transgenic mouse led to a lower
steady-state protein level and to decreased catalytic effi-
ciency in vivo (Gupta et al. 2008). Decreased amounts of
hyperactive mutants were also observed in crude cell
extracts for two patient-derived fibroblast cell lines carrying
the mutations p.I435T/del ex8 (Maclean et al. 2002)o rp .
D444N/p.D444N (Evande et al. 2002). Based on these
observations, we speculate that the more tightly folded
mutants may be recognized by the cellular quality control
machinery, thereby leading to their accelerated degradation.
It should be noted that our study revealed several
limitations of proteolytic experiments for conformational
studies in crude cell extracts. Pulse proteolysis could not be
applied for three of the nine mutant proteins (p.H65R, p.
E302K and p.G307S) because these mutants were substan-
tially cleaved during the proteolytic pulse, even in the
absence of urea. In addition, we experienced difficulties
with the evaluation of the other unfolded mutants (p.
A114V, p.T191M, p.I278T and p.R369C) due to significant
cleavage at the beginning of the apparent transition zone or
precipitation events during the overnight equilibration in
the urea gradient. In this case, the determination of cm
values and subsequent data interpretation must be per-
formed carefully and pulse proteolysis in the urea gradient
474 J Inherit Metab Dis (2012) 35:469–477may indicate changes in thermodynamic stability of
unfolded mutant proteins.
On the other hand, the determination of the rate of
proteolysis with thermolysin under native conditions
appeared to be robust and provided conformational data
about all mutants studied. Despite this, there were some
obstacles while performing this technique: a) the relatively
demanding optimalization of the procedure in order to find
an appropriate ratio of the total protein in lysates to the
thermolysin concentration (w/w) to accurately determine
proteolysis kinetics; b) the presence of a small protein
fraction that was not cleaved according to first-order
kinetics and that remained intact and catalytically active at
the end of experiments (data not shown). Because the small
uncleaved fraction was also observed in mammalian HepG
and HeK cell-lines with endogenous CBS expression (our
unpublished data) but not with purified CBS proteins
(Hnizda et al. 2010), it is possible that the minor fraction
of CBS in cell lysates may result from intermolecular
interactions with small ligands or high molecular weight
molecules such as other proteins or nucleic acids. This
uncleaved fraction is most likely not caused by binding of a
small compound because the dialysis of the bacterial lysate
containing wild-type CBS prior to the assay did not
significantly change the proteolytic time-course (data not
shown). In spite of these limitations, the proteolytic
techniques used in crude cell extracts enabled the expansion
of our knowledge about the conformational properties of
the CBS mutants that are not amenable for purification and
consequently not available for detailed studies by more
conventional methods.
Wepresenthereageneralmethodologicalstrategythatmay
be used directly in crude cell extracts to evaluate properties of
proteins that tend to misfold and aggregate and that may be
important for conformational studies of disease-causing
mutations in the field of inborn errors of metabolism. This
approach may benefit the conformational analysis of mutants
after expression without affinity tags or after endogenous
expression in patient-derived fibroblasts, other available cell
lines or tissues. Proteolytic techniques are able to reveal
conformational abnormalities even in mutant enzymes with
normal catalytic activity and may be applied to the mutational
analysis of non-enzymatic proteins whose functional assays
are lacking or are difficult to employ.
Materials and methods
Materials If not specified otherwise, all chemicals were
purchased from Sigma-Aldrich.
Expression of CBS enzymes and preparation of crude cell
extract The CBS proteins were expressed at 37°C in E. coli
transformed with pHCS3 plasmids that express untagged
full-length wild-type or mutant CBS proteins (Kozich and
Kraus 1992). Crude cell-extracts were prepared as described
previously (Kozich et al. 2010). The protein concentration
was determined using Bradford reagent with bovine serum
albumin as a standard.
Proteolysis with thermolysin under native conditions Crude
cell extracts (final protein concentration 1 mg/ml; total
volume 25 μl) were diluted in 20 mM Tris-HCl (pH 8.0)
containing 10 mM CaCl2, equilibrated at 25°C for
10 minutes and then digested with thermolysin. The
concentration of thermolysin ranged from 0.4 to 200 μg/
ml as described in the Results. At the selected time points,
proteolysis was quenched in 20 mM EDTA.
Pulse proteolysis Pulse proteolysis was performed accord-
ing to a previously reported procedure (Hnizda et al. 2010)
with some modifications. Cell lysates (final protein con-
centration 1 mg/ml; total volume 25 μl) were incubated
overnight at 4°C in 20 mM Tris-HCl (pH 8.0) containing
10 mM CaCl2 and urea (0–7 M). After subsequent
equilibration at 25°C for 10 minutes, the samples were
digested by thermolysin from Bacillus thermoproteolyticus
(0.2 mg/ml) at 25°C. The proteolytic pulse (60 s) was
quenched in 20 mM EDTA.
Because the thermodynamic stability of multimers may be
dependent on protein concentration, we assessed the effect of
different amounts of wild-type CBS in the assay on the
determinedcm values. Pulse proteolysis of the wild-type CBS
was performed for lower concentration of total protein (0.5
or 0.25 mg/ml) that was digested by the corresponding
amount of thermolysin (100 or 50 μg/ml). The lower protein
concentration in pulse proteolysis did not change the
apparent cm values (data not shown). These experiments
showed that lower amounts of CBS proteins in the assay did
not have an effect on the accurate determination of their
thermodynamic stability implying that this approach is also
useful for mutant proteins with decreased steady-state levels.
Western blotting and data fitting The amount of uncleaved
CBS was analyzed under denaturing or native conditions by
the Western blot procedure described previously (Kopecka
et al. 2011). The CBS antigen was detected using purified
chicken anti-hCBS serum H19 (HenA, Czech Republic)
diluted 1:500 in 3% non-fat dry milk in 10 mM Tris-HCl
(pH 7.4) containing 150 mM NaCl. Secondary rabbit anti-
chicken horseradish-peroxidase-cojugated antibody (Ther-
moFischer Scientific) was diluted 1:15,000 in PBS con-
taining 3% non-fat dry milk. The signal was quantified, and
the data were fitted to non-linear curves as reported
previously (Hnizda et al. 2010; Kozich et al. 2010). Each
experiment was carried out twice, each in duplicate; data
J Inherit Metab Dis (2012) 35:469–477 475shown in figures and tables are therefore the means and
standard deviations of four determinations.
Proteolysis under native conditions was evaluated using
the first-order kinetics (Park and Marqusee 2004b). Data
were fitted into the equation as follows:
N ¼ N0   e  kobs t ðÞ þ B; ð1Þ
where N and N0 are the amounts of intact protein, kobs is the
first-rate kinetics constant, t is time and B is the fraction of
protein that was not cleaved via the first-order kinetics and
that remained uncleaved at the end of proteolytic experi-
ment. Data from the pulse proteolysis were fitted into the
sigmoidal equation as follows:
ffold ¼
1
1 þ ep  cm c ðÞ ; ð2Þ
where ffold is a fraction of folded proteins remaining intact
after the proteolytic pulse and is related to the amount of
uncleaved protein after the pulse in absence of urea, cm is
the urea concentration at which ffold is 0.5 and c is the urea
concentration. p is a slope of the curve at cm and reflects
unfolding cooperativity.
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